Bavarian Nordic A/S (OTCMKTS:BVNRY) Shares Pass Below Two Hundred Day Moving Average – Here’s Why

Bavarian Nordic A/S (OTCMKTS:BVNRY)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $9.73 and traded as low as $7.94. Bavarian Nordic A/S shares last traded at $7.94, with a volume of 7,224 shares changing hands.

Bavarian Nordic A/S Trading Up 1.8 %

The firm has a market cap of $1.88 billion, a P/E ratio of 11.51 and a beta of 1.83. The business’s fifty day moving average price is $8.46 and its two-hundred day moving average price is $9.73.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last released its quarterly earnings results on Wednesday, March 5th. The company reported $0.47 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.07. The business had revenue of $299.48 million for the quarter, compared to the consensus estimate of $264.06 million. Bavarian Nordic A/S had a net margin of 18.33% and a return on equity of 10.65%. Research analysts predict that Bavarian Nordic A/S will post 0.67 EPS for the current fiscal year.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.